Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × NETWORK × CX 5461 × Clear all

Phase

Status

Sponsor Class

NIH 2 OTHER 1 NETWORK 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Interventions

Cisplatin 22 Paclitaxel 17 Radiotherapy 16 Carboplatin 16 Cyclophosphamide 13 Vincristine 12 Etoposide 11 Gemcitabine 10 Filgrastim 10 Doxorubicin 10 Temozolomide 8 Docetaxel 8 Topotecan 7 Dexamethasone 7 Taxes 6 Radiation 6 Granulocyte Colony-Stimulating Factor 6 Cytarabine 6 Peripheral Blood Stem Cell Transplantation 5 Oxaliplatin 5 Methotrexate 5 Melphalan 5 Irinotecan 5 Fenretinide 5 Capecitabine 5 etoposide phosphate 4 Trastuzumab 4 Radiotherapy, Conformal 4 Pemetrexed 4 Leucovorin 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02719977 2023-08-04

A Phase I Study of CX5461

Canadian Cancer Trials Group

Phase 1 Completed

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡